Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
Status:
Terminated
Trial end date:
2011-10-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effectiveness of vitamin D3 versus vitamin D2 in
raising vitamin D levels and suppressing parathyroid hormone levels in patients with kidney
disease who are not on dialysis.
Phase:
Phase 3
Details
Lead Sponsor:
The Cleveland Clinic
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins